StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pershing Square Capital Raises Stake in Valeant Pharma (VRX) to 9.9%
November 23, 2015 5:16 PM
In a 13D filing on Valeant Pharma (NYSE: VRX), hedge fund Pershing Square ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
13Ds
Hedge Funds
Hot Hedge Fund News
Short Sales
Trader Talk
Next Articles
Buy Valeant Pharmaceuticals (VRX) Ahead of Investor Day Catalyst - Guggenheim
November 24, 2015 8:02 AM
Form SC 13D/A Valeant Pharmaceuticals Filed by: Pershing Square Capital Management, L.P.
November 23, 2015 5:13 PM